Publication Cover
Journal of Environmental Science and Health, Part A
Toxic/Hazardous Substances and Environmental Engineering
Volume 48, 2013 - Issue 13
364
Views
12
CrossRef citations to date
0
Altmetric
ARTICLES

Life cycle analysis of solvent reduction in pharmaceutical synthesis using continuous adsorption for palladium removal

, &
Pages 1602-1608 | Received 11 Feb 2013, Published online: 15 Aug 2013
 

Abstract

The life cycle emissions associated with the reduction of wastes from an adsorption process to remove palladium complexes in drug manufacture have been evaluated. The study assessed a green improvement to a process step in an active pharmaceutical ingredient synthesis where palladium catalyst is removed from a reaction mixture. The greener process uses a continuous adsorption system, composed of a more efficient adsorbent, consuming less organic solvent and rinse water, which results in less waste disposal. The newer process is also more energy and cost efficient from an operational perspective. There is a 94% reduction in the carbon footprint of the new process when compared to the current operation.

Acknowledgments

Partial support for this has been provided by a grant from the US Environmental Protection Agency, NP 97257006-0. The authors wish to acknowledge Novartis Pharmaceutical Corporation for their support and Thomas Blacklock and Michael Girgis for their assistance.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.